Q4 EPS Estimates for Eastman Chemical Cut by Zacks Research

Eastman Chemical (NYSE:EMN) – Equities research analysts at Zacks Research reduced their Q4 2024 EPS estimates for shares of Eastman Chemical in a research report issued on Thursday, November 14th. Zacks Research analyst R. Department now anticipates that the basic materials company will post earnings of $1.60 per share for the quarter, down from their prior estimate of $1.78. The consensus estimate for Eastman Chemical’s current full-year earnings is $7.63 per share. Zacks Research also issued estimates for Eastman Chemical’s Q1 2025 earnings at $1.86 EPS, Q2 2025 earnings at $2.28 EPS, Q4 2025 earnings at $1.94 EPS, FY2025 earnings at $8.35 EPS, Q1 2026 earnings at $2.03 EPS, Q3 2026 earnings at $2.41 EPS and FY2026 earnings at $9.03 EPS.

EMN has been the topic of several other reports. Deutsche Bank Aktiengesellschaft reduced their price target on Eastman Chemical from $115.00 to $110.00 and set a “hold” rating on the stock in a report on Monday, November 4th. Barclays raised their price target on shares of Eastman Chemical from $103.00 to $111.00 and gave the company an “equal weight” rating in a report on Monday, July 29th. Wells Fargo & Company cut their price objective on shares of Eastman Chemical from $118.00 to $110.00 and set an “equal weight” rating on the stock in a report on Monday, November 4th. StockNews.com raised Eastman Chemical from a “hold” rating to a “buy” rating in a report on Thursday, November 14th. Finally, Bank of America cut Eastman Chemical from a “buy” rating to a “neutral” rating and boosted their price objective for the company from $114.00 to $119.00 in a report on Wednesday, October 16th. Eight analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $111.50.

Eastman Chemical Stock Performance

NYSE:EMN opened at $104.01 on Monday. Eastman Chemical has a fifty-two week low of $80.71 and a fifty-two week high of $114.50. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.78 and a current ratio of 1.52. The stock’s fifty day moving average is $106.19 and its 200 day moving average is $101.49. The firm has a market capitalization of $12.06 billion, a PE ratio of 13.92, a PEG ratio of 0.77 and a beta of 1.44.

Eastman Chemical (NYSE:EMN) last released its quarterly earnings data on Thursday, October 31st. The basic materials company reported $2.26 EPS for the quarter, beating the consensus estimate of $2.14 by $0.12. The business had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.38 billion. Eastman Chemical had a net margin of 9.47% and a return on equity of 15.37%. Eastman Chemical’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the business earned $1.47 earnings per share.

Insider Transactions at Eastman Chemical

In related news, SVP Christopher Moore Killian sold 3,061 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $105.00, for a total transaction of $321,405.00. Following the completion of the sale, the senior vice president now directly owns 12,366 shares in the company, valued at approximately $1,298,430. This trade represents a 19.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.93% of the company’s stock.

Institutional Trading of Eastman Chemical

Several institutional investors have recently made changes to their positions in EMN. Bessemer Group Inc. increased its holdings in Eastman Chemical by 321.2% in the 1st quarter. Bessemer Group Inc. now owns 16,250 shares of the basic materials company’s stock valued at $1,628,000 after purchasing an additional 12,392 shares during the last quarter. Dakota Wealth Management lifted its stake in Eastman Chemical by 13.5% in the second quarter. Dakota Wealth Management now owns 22,280 shares of the basic materials company’s stock valued at $2,183,000 after buying an additional 2,655 shares during the last quarter. Cetera Advisors LLC grew its position in Eastman Chemical by 119.7% during the 1st quarter. Cetera Advisors LLC now owns 10,088 shares of the basic materials company’s stock worth $1,011,000 after purchasing an additional 5,496 shares during the last quarter. Comerica Bank raised its stake in Eastman Chemical by 18.5% during the 1st quarter. Comerica Bank now owns 39,306 shares of the basic materials company’s stock valued at $3,939,000 after acquiring an additional 6,126 shares during the last quarter. Finally, Principal Financial Group Inc. grew its position in Eastman Chemical by 6.8% in the 3rd quarter. Principal Financial Group Inc. now owns 148,176 shares of the basic materials company’s stock valued at $16,588,000 after buying an additional 9,447 shares during the last quarter. Hedge funds and other institutional investors own 83.65% of the company’s stock.

Eastman Chemical Company Profile

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.